Management of hypertension in hemodialysis patients

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The relationship of hypertension with adverse outcomes is uncertain in the hemodialysis population. If hypertension is an etiologically significant cardiovascular risk factor in hemodialysis patients, the first step would be to assess the level of BP accurately. BP obtained at home over a week and averaged using a validated oscillometric automatic device can prove valuable. To the extent BP lowering influences cardiovascular outcomes, home BP of 150/90mm Hg would warrant therapy, since it correlates with target organ damage and hypertension diagnosed by ambulatory BP monitoring. To manage hypertension, limiting dietary sodium intake and individualizing dialysate sodium delivery would be first steps. The magnitude of reduction in BP with dietary sodium restriction and the whether dialysate sodium can be safely limited in those who are hypotension-prone is unclear. Antihypertensive drug therapies can effectively reduce BP and are needed by the vast majority of hemodialysis patients. Whether control of hypertension translates into better outcomes is not known, but collective evidence suggests that hypertension should be controlled in hemodialysis patients.

Original languageEnglish
Pages (from-to)241-248
Number of pages8
JournalHemodialysis International
Volume10
Issue number3
DOIs
StatePublished - Jul 2006

Fingerprint

Renal Dialysis
Hypertension
Dietary Sodium
Dialysis Solutions
Sodium
Ambulatory Monitoring
Hypotension
Antihypertensive Agents
Drug Therapy
Equipment and Supplies
Population

Keywords

  • Ambulatory BP monitoring
  • End-stagerenal disease
  • Hemodialysis
  • Home BP monitoring
  • Hypertension

ASJC Scopus subject areas

  • Hematology

Cite this

Management of hypertension in hemodialysis patients. / Agarwal, Rajiv.

In: Hemodialysis International, Vol. 10, No. 3, 07.2006, p. 241-248.

Research output: Contribution to journalArticle

@article{08c8e72c5df143aca0d5afa0f36d4ca8,
title = "Management of hypertension in hemodialysis patients",
abstract = "The relationship of hypertension with adverse outcomes is uncertain in the hemodialysis population. If hypertension is an etiologically significant cardiovascular risk factor in hemodialysis patients, the first step would be to assess the level of BP accurately. BP obtained at home over a week and averaged using a validated oscillometric automatic device can prove valuable. To the extent BP lowering influences cardiovascular outcomes, home BP of 150/90mm Hg would warrant therapy, since it correlates with target organ damage and hypertension diagnosed by ambulatory BP monitoring. To manage hypertension, limiting dietary sodium intake and individualizing dialysate sodium delivery would be first steps. The magnitude of reduction in BP with dietary sodium restriction and the whether dialysate sodium can be safely limited in those who are hypotension-prone is unclear. Antihypertensive drug therapies can effectively reduce BP and are needed by the vast majority of hemodialysis patients. Whether control of hypertension translates into better outcomes is not known, but collective evidence suggests that hypertension should be controlled in hemodialysis patients.",
keywords = "Ambulatory BP monitoring, End-stagerenal disease, Hemodialysis, Home BP monitoring, Hypertension",
author = "Rajiv Agarwal",
year = "2006",
month = "7",
doi = "10.1111/j.1542-4758.2006.00102.x",
language = "English",
volume = "10",
pages = "241--248",
journal = "Hemodialysis International",
issn = "1492-7535",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Management of hypertension in hemodialysis patients

AU - Agarwal, Rajiv

PY - 2006/7

Y1 - 2006/7

N2 - The relationship of hypertension with adverse outcomes is uncertain in the hemodialysis population. If hypertension is an etiologically significant cardiovascular risk factor in hemodialysis patients, the first step would be to assess the level of BP accurately. BP obtained at home over a week and averaged using a validated oscillometric automatic device can prove valuable. To the extent BP lowering influences cardiovascular outcomes, home BP of 150/90mm Hg would warrant therapy, since it correlates with target organ damage and hypertension diagnosed by ambulatory BP monitoring. To manage hypertension, limiting dietary sodium intake and individualizing dialysate sodium delivery would be first steps. The magnitude of reduction in BP with dietary sodium restriction and the whether dialysate sodium can be safely limited in those who are hypotension-prone is unclear. Antihypertensive drug therapies can effectively reduce BP and are needed by the vast majority of hemodialysis patients. Whether control of hypertension translates into better outcomes is not known, but collective evidence suggests that hypertension should be controlled in hemodialysis patients.

AB - The relationship of hypertension with adverse outcomes is uncertain in the hemodialysis population. If hypertension is an etiologically significant cardiovascular risk factor in hemodialysis patients, the first step would be to assess the level of BP accurately. BP obtained at home over a week and averaged using a validated oscillometric automatic device can prove valuable. To the extent BP lowering influences cardiovascular outcomes, home BP of 150/90mm Hg would warrant therapy, since it correlates with target organ damage and hypertension diagnosed by ambulatory BP monitoring. To manage hypertension, limiting dietary sodium intake and individualizing dialysate sodium delivery would be first steps. The magnitude of reduction in BP with dietary sodium restriction and the whether dialysate sodium can be safely limited in those who are hypotension-prone is unclear. Antihypertensive drug therapies can effectively reduce BP and are needed by the vast majority of hemodialysis patients. Whether control of hypertension translates into better outcomes is not known, but collective evidence suggests that hypertension should be controlled in hemodialysis patients.

KW - Ambulatory BP monitoring

KW - End-stagerenal disease

KW - Hemodialysis

KW - Home BP monitoring

KW - Hypertension

UR - http://www.scopus.com/inward/record.url?scp=33745259503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745259503&partnerID=8YFLogxK

U2 - 10.1111/j.1542-4758.2006.00102.x

DO - 10.1111/j.1542-4758.2006.00102.x

M3 - Article

C2 - 16805884

AN - SCOPUS:33745259503

VL - 10

SP - 241

EP - 248

JO - Hemodialysis International

JF - Hemodialysis International

SN - 1492-7535

IS - 3

ER -